跳至主要内容
临床试验/ACTRN12622001301752
ACTRN12622001301752尚未招募未知

A Prospective study of the Safety and Effectiveness of Uterine Artery Embolization for the treatment of Endometriosis (UAE-E) – a Pilot Study

The Alfred Hospital0 个研究点目标入组 6 人开始时间: 2022年10月7日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • 1. Completed family – no desire for future pregnancies or fertility treatment.
  • 2. Pre-menopausal with regular menstrual periods.
  • 3. Pelvic endometriosis as confirmed by laparoscopy.
  • 4. Symptoms of endometriosis impacting quality of life as evidenced by BSGE pelvic pain questionnaire and including one of the following:
  • a) period-related pain (dysmenorrhoea) affecting daily activities and quality of life
  • b) deep pain during or after sexual intercourse
  • c) period-related or cyclical gastrointestinal symptoms, in particular, painful bowel movements
  • d) period-related or cyclical urinary symptoms, in particular, blood in the urine or pain passing urine
  • 5. Signed study participant information and consent form.

排除标准

  • 1. Desire for future pregnancies or fertility treatment.
  • 2. Perimenopausal by clinical criteria or irregular periods.
  • 3. Previous hysterectomy or previous uterine artery embolisation.
  • 4. Other co-morbidities that are likely to be causing chronic abdominal or pelvic pain.
  • 5. Iodine contrast allergy
  • 6. Active pelvic infection or inflammatory disease
  • 7. Severe renal insufficiency
  • 8. Gynaecological malignancy
  • 9. ECOG 0-1

研究者

发起方
The Alfred Hospital

相似试验

A Prospective study of the Safety and Effectiveness... | 临床试验